TY - JOUR
T1 - Contribution of nitric oxide in the contraction-induced rapid vasodilation in young and older adults
AU - Casey, Darren P.
AU - Walker, Branton G.
AU - Ranadive, Sushant M.
AU - Taylor, Jennifer L.
AU - Joyner, Michael J.
PY - 2013/8/15
Y1 - 2013/8/15
N2 - Contribution of nitric oxide in the contraction-induced rapid vasodilation in young and older adults. J Appl Physiol 115: 446-455, 2013. First published June 20, 2013; doi:10.1152/japplphysiol.00446.2013.-We tested the hypothesis that reduced nitric oxide (NO) bioavailability contributes to the attenuated peak and total vasodilation following singlemuscle contractions in older adults. Young (n = 10; 24 ± 2 yr) and older (n = 10; 67 ± 2 yr) adults performed single forearm contractions at 10, 20, and 40% of maximum during saline infusion (control) and NO synthase (NOS) inhibition via NG-monomethyl-L-arginine. Brachial artery diameters and velocities were measured using Doppler ultrasound and forearm vascular conductance (FVC; in ml.min 1.100 mmHg-1) was calculated from blood flow (ml/min) and blood pressure (mmHg). Peak and total vasodilator responses [change (δ) in FVC from baseline] were attenuated in older adults at all intensities (P < 0.05). NOS inhibition reduced the peak δFVC at 10% (88 ± 12 vs. 52 ± 9 ml.min-1.100 mmHg-1), 20% (125 ± 13 vs. 83 ± 13 ml.min-1.100 mmHg-1), and 40% (207 ± 26 vs. 133 ± 20 ml.min-1.100 mmHg-1) in young subjects, (P < 0.05 for all) and in older adults at 10% (59 ± 5 vs. 47±7 ml.min-1.100 mmHg-1, P<0.05) and 20% (88±9 vs. 68± 9 ml.min-1.100 mmHg-1, P < 0.05), but not 40% (128 ± 12 vs. 105 ± 11 ml.min-1.100 mmHg -1, P = 0.11). The relative (%) reduction in peak δFVC due to NOS inhibition was greater in young vs. older adults at 20% (-36 ± 5 vs. -23 ± 5%, P < 0.05) and 40% (-35 ± 6 vs. -16 ± 7%, P < 0.05). The reduction in the total vasodilator response (area under the curve) with NOS inhibition was also greater in young vs. older adults at all intensities. Our data suggest that contraction-induced rapid vasodilation is mediated in part by NO, and that the contribution of NO is greater in young adults.
AB - Contribution of nitric oxide in the contraction-induced rapid vasodilation in young and older adults. J Appl Physiol 115: 446-455, 2013. First published June 20, 2013; doi:10.1152/japplphysiol.00446.2013.-We tested the hypothesis that reduced nitric oxide (NO) bioavailability contributes to the attenuated peak and total vasodilation following singlemuscle contractions in older adults. Young (n = 10; 24 ± 2 yr) and older (n = 10; 67 ± 2 yr) adults performed single forearm contractions at 10, 20, and 40% of maximum during saline infusion (control) and NO synthase (NOS) inhibition via NG-monomethyl-L-arginine. Brachial artery diameters and velocities were measured using Doppler ultrasound and forearm vascular conductance (FVC; in ml.min 1.100 mmHg-1) was calculated from blood flow (ml/min) and blood pressure (mmHg). Peak and total vasodilator responses [change (δ) in FVC from baseline] were attenuated in older adults at all intensities (P < 0.05). NOS inhibition reduced the peak δFVC at 10% (88 ± 12 vs. 52 ± 9 ml.min-1.100 mmHg-1), 20% (125 ± 13 vs. 83 ± 13 ml.min-1.100 mmHg-1), and 40% (207 ± 26 vs. 133 ± 20 ml.min-1.100 mmHg-1) in young subjects, (P < 0.05 for all) and in older adults at 10% (59 ± 5 vs. 47±7 ml.min-1.100 mmHg-1, P<0.05) and 20% (88±9 vs. 68± 9 ml.min-1.100 mmHg-1, P < 0.05), but not 40% (128 ± 12 vs. 105 ± 11 ml.min-1.100 mmHg -1, P = 0.11). The relative (%) reduction in peak δFVC due to NOS inhibition was greater in young vs. older adults at 20% (-36 ± 5 vs. -23 ± 5%, P < 0.05) and 40% (-35 ± 6 vs. -16 ± 7%, P < 0.05). The reduction in the total vasodilator response (area under the curve) with NOS inhibition was also greater in young vs. older adults at all intensities. Our data suggest that contraction-induced rapid vasodilation is mediated in part by NO, and that the contribution of NO is greater in young adults.
KW - Aging
KW - Muscle contraction
KW - Nitric oxide
KW - Vasodilation
UR - http://www.scopus.com/inward/record.url?scp=84882574798&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84882574798&partnerID=8YFLogxK
U2 - 10.1152/japplphysiol.00446.2013
DO - 10.1152/japplphysiol.00446.2013
M3 - Article
C2 - 23788575
AN - SCOPUS:84882574798
SN - 8750-7587
VL - 115
SP - 446
EP - 455
JO - Journal of Applied Physiology
JF - Journal of Applied Physiology
IS - 4
ER -